- Report
- October 2026
- 504 Pages
Global
From €5347EUR$5,850USD£4,568GBP
- Report
- July 2026
- 200 Pages
Global
From €7302EUR$7,990USD£6,240GBP
- Report
- April 2026
- 200 Pages
Global
From €2733EUR$2,990USD£2,335GBP
- Report
- September 2026
- 184 Pages
Global
From €3240EUR$3,545USD£2,769GBP
€3600EUR$3,939USD£3,076GBP
- Report
- July 2026
- 120 Pages
Global
From €4433EUR$4,850USD£3,788GBP
- Report
- November 2025
- 210 Pages
Global
From €4433EUR$4,850USD£3,788GBP
- Report
- September 2026
- 190 Pages
Global
From €3240EUR$3,545USD£2,769GBP
€3600EUR$3,939USD£3,076GBP
- Report
- September 2026
- 183 Pages
Global
From €3240EUR$3,545USD£2,769GBP
€3600EUR$3,939USD£3,076GBP
- Report
- September 2026
- 181 Pages
Global
From €3240EUR$3,545USD£2,769GBP
€3600EUR$3,939USD£3,076GBP
- Report
- September 2026
- 182 Pages
Global
From €3240EUR$3,545USD£2,769GBP
€3600EUR$3,939USD£3,076GBP
- Report
- September 2026
- 187 Pages
Global
From €3240EUR$3,545USD£2,769GBP
€3600EUR$3,939USD£3,076GBP
- Report
- September 2026
- 181 Pages
Global
From €3240EUR$3,545USD£2,769GBP
€3600EUR$3,939USD£3,076GBP
- Report
- September 2026
- 195 Pages
Global
From €3240EUR$3,545USD£2,769GBP
€3600EUR$3,939USD£3,076GBP
- Report
- September 2026
- 194 Pages
Global
From €3240EUR$3,545USD£2,769GBP
€3600EUR$3,939USD£3,076GBP
- Report
- September 2026
- 193 Pages
Global
From €3240EUR$3,545USD£2,769GBP
€3600EUR$3,939USD£3,076GBP
- Report
- September 2026
- 182 Pages
Global
From €3240EUR$3,545USD£2,769GBP
€3600EUR$3,939USD£3,076GBP
- Report
- September 2026
- 194 Pages
Global
From €3240EUR$3,545USD£2,769GBP
€3600EUR$3,939USD£3,076GBP
- Report
- February 2026
- 250 Pages
Global
From €4104EUR$4,490USD£3,506GBP
- Report
- August 2026
- 337 Pages
Global
From €2285EUR$2,500USD£1,952GBP
- Report
- August 2026
- 140 Pages
Global
From €4341EUR$4,750USD£3,709GBP

The Immune Disorders Drugs market includes drugs used to treat Inflammatory Bowel Disease (IBD). IBD is a chronic condition that causes inflammation of the digestive tract, leading to abdominal pain, diarrhea, and other symptoms. IBD drugs are used to reduce inflammation and improve symptoms. These drugs include corticosteroids, immunomodulators, biologics, and other medications. Corticosteroids are used to reduce inflammation and suppress the immune system, while immunomodulators are used to modify the immune system's response to inflammation. Biologics are used to target specific molecules involved in the inflammatory process.
Some companies in the IBD drug market include AbbVie, Amgen, AstraZeneca, Boehringer Ingelheim, Janssen, Merck, Pfizer, and Takeda. Show Less Read more